Profile
Bruce N.
Rogers is President at Morphic Therapeutic, Inc. since 2022.
Dr. Rogers is Venture Partner at JP Morgan Life Sciences Private Capital starting in 2026.
Formerly, Dr. Rogers was President at Morphic Holding, Inc. in 2024.
Dr. Rogers was Head-Neuro Opportunities at Pfizer Inc. from 2014 to 2016.
Dr. Rogers was Scientist at Pharmacia & Upjohn Co. LLC from 1998 to 2003.
Dr. Rogers earned a doctorate from the University of California, Irvine and an undergraduate degree from the University of Minnesota.
Bruce Rogers active positions
| Companies | Position | Start |
|---|---|---|
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | President | 01/05/2022 |
Former positions of Bruce Rogers
| Companies | Position | End |
|---|---|---|
| MORC HOLD | Chief Executive Officer | 02/01/2024 |
| PFIZER INC. | Corporate Officer/Principal | 01/01/2016 |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Corporate Officer/Principal | 01/08/2003 |
Training of Bruce Rogers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia & Upjohn Co. LLC
Pharmacia & Upjohn Co. LLC Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical goods | Health Technology |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Researches and develops small molecules to block transmembrane integrin receptors | Health Technology |
Morphic Holding, Inc.
Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
- Stock Market
- Insiders
- Bruce Rogers
















